Open RFP

Nanotechnology Orchestrated Viral Annihilation (NOVA) – DTRA

Description: DTRA’s R&D Chemical and Biological Technologies Directorate Medical Division, supporting JSTO and collaborating with CPE-CBRND, seeks prototype nanotechnology-based medical countermeasures against viral threats to warfighters before and after exposure. The work calls for a broad-spectrum antiviral prototype demonstrated in vitro against at least five viruses and in vivo against at least one, with ruggedized formulations suitable for multiple administration routes and austere conditions. It also seeks scalable manufacturing through Phase 1 clinical trials and a credible regulatory pathway to licensure, including anticipated FDA engagement.

Released
Oct 19, 2026
Closes
Nov 11, 2026(18 days left)
See your top accountsScan your site in seconds. Starbridge identifies your ICP and surfaces emerging opportunities from board meetings, job changes, new grants, contract expirations, RFPs, and more.
See your top 10 accounts